IL6 and lung carcinoma: The engagement of TLRs induced NF-κB activation via the TRAF6-TAK1 signaling axis and increases in the production of IL-6, CCL2, CCL20, vascular endothelial growth factor (VEGF), and MMP2, thereby enhancing lung cancer migration and invasion [20].